Medication info

Conex Tablet 5/80mg

Prescription medicationExpired
Ingredient · strength
Valsartan›Strength being verifiedAmlodipine Besylate›Strength being verified
Manufacturer / importer
Bionex Co., Ltd.
Appearance
Dark yellow round film-coated tablets
Packaging
28 tablets/box [14 tablets/PTP×2], 30 tablets/bottle
Approval status
Expired

MFDS item code 201309120 · Approved 2013.08.30

This product's status changed to Expired on 2023.08.30. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who uses it
Adults · Children
Adult dosage
The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended to take the medicine at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before starting this medicine. However, if blood pressure is not adequately controlled with monotherapy using either component, an immediate switch to this medicine may be considered as follows. * Valsartan/amlodipine besylate combination product 5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Adults aged 65 years or older: Use caution when increasing the dose.
Children's dosage
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
Bionex Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medicine is used for patients with essential hypertension whose blood pressure is not sufficiently controlled with monotherapy with either amlodipine or valsartan. It helps reduce the risk of cardiovascular complications by effectively lowering blood pressure. Therefore, it is used for the treatment of essential hypertension.

Dosage and Administration

Adult dosage

The recommended dose is 1 tablet once daily, taken with water, regardless of meals. It is recommended to take the medicine at the same time each day, if possible (e.g., in the morning). It is recommended that the dose be adjusted using the individual components (amlodipine or valsartan) before starting this medicine. However, if blood pressure is not adequately controlled with monotherapy using either component, an immediate switch to this medicine may be considered as follows. * Valsartan/amlodipine besylate combination product 5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer this medicine to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Adults aged 65 years or older: Use caution when increasing the dose.

Children's dosage

The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication should be discontinued immediately if pregnancy is confirmed, as it can cause serious harm to the fetus and newborn if taken during the second and third trimesters. It should not be administered to patients with allergies to any of its components, to pregnant or breastfeeding women, or to patients with severe renal or hepatic dysfunction. Careful observation of patients with sodium or fluid depletion is necessary to avoid hypotension. If hypotension occurs, the patient should be laid down and fluid therapy should be provided if necessary. Blood potassium levels should be monitored frequently in patients with high potassium levels or those taking medications that may increase potassium. Patients with renal issues or those who have undergone kidney transplantation, history of angioedema, patients with heart failure or post-myocardial infarction, and those with aortic stenosis should use this medication cautiously. This medication may cause various side effects such as dizziness, headache, edema, hypotension, cough, digestive disorders, skin rashes, etc., and patients should consult a doctor if any unusual symptoms occur. Caution is recommended as dizziness or fatigue may occur while driving or operating machinery. This medication may interact with other blood pressure medications, potassium supplements, non-steroidal anti-inflammatory drugs (NSAIDs), and certain antibiotics; therefore, patients should inform their doctor of any medications they are taking. Women who are pregnant or planning to become pregnant should not use this medication, and breastfeeding women should also avoid it. Safety and efficacy in children under 18 years of age have not been sufficiently established, so its use is not recommended. Overdosage may lead to severe hypotension or cardiac arrhythmias; therefore, patients should adhere to the prescribed dosage and seek medical attention immediately in case of overdose. Patients taking this medication should have their blood pressure, renal function, and serum electrolyte levels checked regularly to ensure safe treatment.

Side effects

  • Pharyngitis
  • influenza
  • hypersensitivity
  • visual impairment
  • anxiety
  • headache
  • dizziness
  • drowsiness
  • orthostatic dizziness
  • paresthesia
Show 106 more
  • vertigo
  • tinnitus
  • tachycardia
  • palpitations
  • syncope
  • orthostatic hypotension
  • hypotension
  • cough
  • pain in the throat and larynx
  • diarrhea
  • nausea
  • abdominal pain
  • constipation
  • dry mouth
  • rash
  • erythema
  • hyperhidrosis
  • itching
  • joint swelling
  • low back pain
  • arthritis
  • muscle spasms
  • fatigue
  • polyuria
  • nocturia
  • erectile dysfunction
  • edema
  • localized edema
  • facial edema
  • peripheral edema
  • tiredness
  • flushing
  • weakness
  • facial flushing
  • decreased hemoglobin
  • decreased hematocrit
  • neutropenia
  • thrombocytopenia
  • serum sickness-related hypersensitivity
  • increased serum potassium
  • vasculitis
  • increased liver function tests
  • angioedema
  • myalgia
  • renal failure
  • kidney damage
  • increased serum creatinine
  • insomnia
  • decreased libido
  • pharyngitis
  • rhinitis
  • sinusitis
  • upper respiratory infection
  • viral infection
  • diplopia
  • thrombocytopenia
  • leukopenia
  • allergic reaction
  • hyperglycemia
  • insomnia
  • mood changes
  • tremors
  • sensory impairment
  • taste disorder
  • peripheral neuropathy
  • hypertonia
  • arrhythmia
  • bradycardia
  • atrial fibrillation
  • ventricular tachycardia
  • myocardial infarction
  • dyspnea
  • rhinitis
  • vomiting
  • dyspepsia
  • pancreatitis
  • gastritis
  • gingival hyperplasia
  • hepatitis
  • jaundice
  • alopecia
  • purpura
  • skin depigmentation
  • photosensitivity reaction
  • angioedema
  • urticaria
  • erythema multiforme
  • Stevens-Johnson syndrome
  • myalgia
  • urinary disorder
  • enuresis
  • gynecomastia
  • pain
  • lethargy
  • chest pain
  • weight loss
  • weight gain
  • increased liver enzymes
  • chest discomfort
  • abdominal discomfort
  • gastroesophageal reflux
  • neck pain
  • hypercholesterolemia
  • hypoglycemia
  • neuroexcitability
  • Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture, and should be kept at room temperature between 1 and 30 degrees Celsius. Storing it this way will help maintain its effectiveness for a longer time.

Appearance and packaging

Appearance

Dark yellow round film-coated tablets

Package unit

28 tablets/box [14 tablets/PTP×2], 30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.